Active	Status	Sponsor type	Region	Phase	Filter
13 Active 3 Inactive 16 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zhou, Jun
TQB2102-Ib/II-01, NCT06431490: A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer	Recruiting	1/2	103	RoW	TQB2102 for injection	Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.	Biliary Tract Cancer	05/25	12/25
NCT04467853: A Clinical Study to Evaluate CAR-T Cell-based Medicinal Product in the Treatment of Advanced Solid Tumors	Terminated	1	34	RoW	LCAR-C18S cells	Shanghai East Hospital, Nanjing Legend Biotech Co.	Solid Tumors, Adult	07/23	07/23
NCT06197178: A Study of LCAR-G08 in Subjects With Advanced Gastrointestinal Tumors Expressing Guanylyl Cyclase C (GCC)	Recruiting	1	42	RoW	LCAR-G08 cells	Peking University, Nanjing Legend Biotech Co.	Advanced Gastrointestinal Tumors	11/25	03/28
NCT05621486: A Clinical Study to Evaluate B4T2-001 CAR T Cells in the Treatment of Advanced Solid Tumors	Active, not recruiting	1	36	RoW	B4T2-001 Autologous CAR T cells	Shanghai East Hospital, Bio4T2 LLC	Advanced Solid Tumor	12/24	12/26
NCT06072989: Repeat Intravenous Infusions of B4T2-001 CAR-T Without Lymphodepleting Chemotherapy for Solid Tumors	Recruiting	1	24	RoW	B4T2-001 autologous CAR-T	Shanghai East Hospital, Bio4T2 LLC	Advanced Solid Tumor	03/25	03/27